Engineering synthetic enhancers and gene circuits to understand and overcome cancer therapy resistance
Duration: 48 months, Funding volume: € 899,099
Therapeutic targeting of EGFR in colorectal cancer as a novel approach to predict and enhance tumor antigenicity and response to checkpoint inhibitors
Duration: 54 months, Funding volume: € 999,500
Molecular analysis of interactions between pathogens and host organisms
Duration: 39 months, Funding volume: € 610,000